Caveats and pitfalls associated with researching community engagement in the context of HIV vaccine trials.

scientific article

Caveats and pitfalls associated with researching community engagement in the context of HIV vaccine trials. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/1359105317745367
P698PubMed publication ID29243520

P50authorPeter A. NewmanQ40025590
Leslie SwartzQ46205941
Anthea LeschQ61980944
Ashraf KageeQ77644853
P2093author name stringZuhayr Kafaar
Anneliese De Wet
P2860cites workGrand challenges in global health: community engagement in research in developing countriesQ21092370
Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participationQ30233275
High HIV prevalence among men who have sex with men in Soweto, South Africa: results from the Soweto Men's StudyQ33925709
Benefits and payments for research participants: experiences and views from a research centre on the Kenyan coastQ34314980
"If It's Not Working, Why Would They Be Testing It?": mental models of HIV vaccine trials and preventive misconception among men who have sex with men in IndiaQ34898392
Ancillary care in South African HIV vaccine trials: addressing needs, drafting protocols, and engaging communityQ34903079
Evaluating community engagement in global health research: the need for metricsQ35679041
Towards a Science of Community Stakeholder Engagement in Biomedical HIV Prevention Trials: An Embedded Four-Country Case StudyQ35752023
Beginning community engagement at a busy biomedical research programme: experiences from the KEMRI CGMRC-Wellcome Trust Research Programme, Kilifi, KenyaQ37192415
Advancing community stakeholder engagement in biomedical HIV prevention trials: principles, practices and evidenceQ38244981
African American and Latina community health workers engage PhotoPAR as a resource in a post-disaster context: Katrina at 5 yearsQ39121402
Three ways of talking about health in communities targeted for regeneration: interviews with community professionalsQ39826040
Community participation in AIDS vaccine trials: empowerment or science?Q40324433
Factors related to the willingness of young gay men to participate in preventive HIV vaccine trialsQ41609952
'It looks like you just want them when things get rough': civil society perspectives on negative trial results and stakeholder engagement in HIV prevention trialsQ43497184
Willingness to participate in HIV vaccine trials among men who have sex with men in Chennai and Mumbai, IndiaQ44956749
". . . I've Gone Through This My Own Self, So I Practice What I Preach . . . ".Q47259140
Health literacy and community empowerment: it is more than just reading, writing and countingQ47791643
"Speaking the dialect": understanding public discourse in the aftermath of an HIV vaccine trial shutdown.Q51692824
Willingness to Volunteer in Future Preventive HIV Vaccine Trials: Issues and Perspectives From Three U.S. CommunitiesQ58214100
A social vaccine? Social and structural contexts of HIV vaccine acceptability among most-at-risk populations in ThailandQ58452373
Towards a science of community engagementQ58452422
P433issue1
P921main subjectcommunity engagementQ5154950
P304page(s)82-91
P577publication date2017-12-15
P1433published inJournal of Health PsychologyQ6295276
P1476titleCaveats and pitfalls associated with researching community engagement in the context of HIV vaccine trials
P478volume25

Reverse relations

Q58595713Stakeholder engagement to inform HIV clinical trials: a systematic review of the evidencecites workP2860